111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.34%
Revenue growth under 50% of CX's 14.24%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-70.43%
Negative gross profit growth while CX is at 16.98%. Joel Greenblatt would examine cost competitiveness or demand decline.
-91.94%
Negative EBIT growth while CX is at 44.41%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-91.94%
Negative operating income growth while CX is at 44.41%. Joel Greenblatt would press for urgent turnaround measures.
1.19%
Net income growth under 50% of CX's 52.84%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.61%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1.64%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.14%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
336.67%
Positive 10Y revenue/share CAGR while CX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
172.59%
5Y revenue/share CAGR above 1.5x CX's 88.48%. David Dodd would look for consistent product or market expansions fueling outperformance.
91.43%
3Y revenue/share CAGR at 75-90% of CX's 105.87%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
527.76%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
372.68%
5Y net income/share CAGR at 75-90% of CX's 458.52%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
170.55%
3Y net income/share CAGR above 1.5x CX's 45.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
118.86%
5Y equity/share CAGR above 1.5x CX's 50.85%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.95%
3Y equity/share CAGR at 75-90% of CX's 68.01%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.